Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laura A Linynsky Insider Profile
4 Followers
Laura A Linynsky, Director at Pediatrix Medical Group, holds 30.80K shares in Pediatrix Medical Group (Ticker: MD). Most recently, Laura A Linynsky Sold $7,000 shares of Pediatrix Medical Group on Aug 29, 2024 for an estimated value of 78.12K.
Laura A Linynsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Laura A Linynsky holds in companies
Most Profitable Insider Trade
The most profitable trade made by Laura A Linynsky
Laura A Linynsky's Trading History
List of latest transactions for each holding click on a transaction to see Laura A Linynsky's performance on stock
You May Also Like
Laura A Linynsky insider profile FAQ
What is the percentage of profitable transactions made by Laura A Linynsky?
The percentage of profitable transactions made by Laura A Linynsky is ―.
What is the average return per transaction made by Laura A Linynsky?
The average return per transaction made by Laura A Linynsky is ―.
What stocks does Laura A Linynsky hold?
Laura A Linynsky holds: MD stocks.
What was Laura A Linynsky’s latest transaction?
Laura A Linynsky latest transaction was an Informative Sell of $78.12K.
What was Laura A Linynsky's most profitable transaction?
Laura A Linynsky’s most profitable transaction was an Informative Sell of MD stock on August 29, 2024. The return on the trade was -42.80%.
What is Laura A Linynsky's role in Pediatrix Medical Group?
Laura A Linynsky's role in Pediatrix Medical Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.